Status History
2026-07-09
OPEN → INELIGIBLE
· This URL is a press release announcing Novo Nordisk Foundation transferring DKK 5.5B to BioInnovation Institute (BII) — there is no direct application embedded here. More critically, BII's mandate is explicitly to 'strengthen innovation in Denmark and Europe'; its programs are physically anchored in Innovation District Copenhagen and target startups able to participate in-person. The applicant is based in Lagos, Nigeria with no European institutional affiliation, creating a hard geographic residency/presence blocker.